4basebio PLC (FRA:88Q)
Germany · Delayed Price · Currency is EUR 10.60
0.00 (0.00%)
Last updated: Jul 31, 2025
Intra-Cellular Therapies Revenue
In the year 2024, 4basebio had annual revenue of 933.00K GBP with 84.39% growth. 4basebio had revenue of 605.00K in the half year ending December 31, 2024, with 421.55% growth.
Revenue
933.00K GBP
Revenue Growth
+84.39%
P/S Ratio
152.66
Revenue / Employee
8.48K GBP
Employees
110
Market Cap
172.24M USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 933.00K | 427.00K | 84.39% |
| Dec 31, 2023 | 506.00K | 238.00K | 88.81% |
| Dec 31, 2022 | 268.00K | -70.00K | -20.71% |
| Dec 31, 2021 | 338.00K | -124.00K | -26.84% |
| Dec 31, 2020 | 462.00K | -346.00K | -42.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.89B |
| Siemens Aktiengesellschaft | 77.82B |
| Deutsche Telekom AG | 120.25B |
| Allianz SE | 109.03B |
| Siemens Energy AG | 37.44B |
| Rheinmetall AG | 10.48B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
| Deutsche Bank Aktiengesellschaft | 30.07B |